(Press-News.org) In multiple sclerosis, the immune system attacks nerves in the brain and spinal cord, causing movement problems, muscle weakness and loss of vision. Immune cells called dendritic cells, which were previously thought to contribute to the onset and development of multiple sclerosis, actually protect against the disease in a mouse model, according to a study published by Cell Press in the August issue of the journal Immunity. These new insights change our fundamental understanding of the origins of multiple sclerosis and could lead to the development of more effective treatments for the disease.
"By transfusing dendritic cells into the blood, it may be possible to reduce autoimmunity," says senior study author Ari Waisman of University Medical Center of Johannes Gutenberg University Mainz. "Beyond multiple sclerosis, I can easily imagine that this approach could be applied to other autoimmune diseases, such as inflammatory bowel disease and psoriasis."
In an animal model of multiple sclerosis known as experimental autoimmune encephalomyelitis (EAE), immune cells called T cells trigger the disease after being activated by other immune cells called antigen-presenting cells (APCs). Dendritic cells are APCs capable of activating T cells, but it was not known whether dendritic cells are the APCs that induce EAE.
In the new study, Waisman and his team used genetic methods to deplete dendritic cells in mice. Unexpectedly, these mice were still susceptible to EAE and developed worse autoimmune responses and disease clinical scores, suggesting that dendritic cells are not required to induce EAE and other APCs stimulate T cells to trigger the disease. The researchers also found that dendritic cells reduce the responsiveness of T cells and lower susceptibility to EAE by increasing the expression of PD-1 receptors on T cells.
"Removing dendritic cells tips the balance toward T cell-mediated autoimmunity," says study author Nir Yogev of University Medical Center of Johannes Gutenberg University Mainz. "Our findings suggest that dendritic cells keep immunity under check, so transferring dendritic cells to patients with multiple sclerosis could cure defects in T cells and serve as an effective intervention for the disease."
###Yogev et al.: "Dendritic Cells Ameliorate Autoimmunity in the CNS by Controlling the Homeostasis of PD-1 Receptor+ Regulatory T Cells."
Discovery of immune cells that protect against multiple sclerosis offers hope for new treatment
2012-08-16
ELSE PRESS RELEASES FROM THIS DATE:
Scripps Research scientists find an important molecular trigger for wound-healing
2012-08-16
LA JOLLA, CA – August 16, 2012 – Scientists at The Scripps Research Institute have made a breakthrough in understanding a class of cells that help wounds in skin and other epithelial tissues heal, uncovering a molecular mechanism that pushes the body into wound-repair mode.
The findings, which appear in an advance, online version of the Immunity on August 16, 2012, focus on cells known as γδ (gamma delta) T cells. The new study demonstrates a skin-cell receptor hooks up with a receptor on γδ T-cells to stimulate wound healing.
"This is a major activation ...
Invasive brittle star species hits Atlantic Ocean
2012-08-16
Coral Reefs, the Journal of the International Society for Reef Studies, has published online a study co-written by Dr. Gordon Hendler of the Natural History Museum of Los Angeles County (NHM) about an invasive species of brittle star, Ophiothela mirabilis. The species was previously restricted to Pacific waters, but surprisingly, growing populations have established themselves at distant points in the Atlantic. Its presence near Brazilian and Caribbean ports indicates that O. mirabilis could have been spread by shipping.
The marine animal is colorful and six-rayed. It ...
Some like it hot: Tropical species 'not as vulnerable' to climate change extinction
2012-08-16
In the face of a changing climate many species must adapt or perish. Ecologists studying evolutionary responses to climate change forecast that cold-blooded tropical species are not as vulnerable to extinction as previously thought. The study, published in the British Ecological Society's Functional Ecology, considers how fast species can evolve and adapt to compensate for a rise in temperature.
The research, carried out at the University of Zurich, was led by Dr Richard Walters, now at Reading University, alongside David Berger now at Uppsala University and Wolf Blanckenhorn, ...
Yoga: A cost-effective treatment for back pain sufferers?
2012-08-16
Specialised group yoga classes could provide a cost-effective way of treating patients with chronic or recurrent low back pain, according to the UK's largest ever study of the benefits of yoga.
Led by the University of York, and funded by Arthritis Research UK, the study provides an evaluation of a specially-developed 12-week group yoga intervention programme compared to conventional general practitioner (GP) care alone.
The results published in Spine, show that the yoga intervention programme – 'Yoga for Healthy Lower Backs' - is likely to be cost effective for both ...
Tibetan Plateau may be older than previously thought
2012-08-16
The growth of high topography on the Tibetan Plateau in Sichuan, China, began much earlier than previously thought, according to an international team of geologists who looked at mountain ranges along the eastern edge of the plateau.
The Indian tectonic plate began its collision with Asia between 55 and 50 million years ago, but "significant topographic relief existed adjacent to the Sichuan Basin prior to the Indo-Asian collision," the researchers report online in Nature Geoscience.
"Most researchers have thought that high topography in eastern Tibet developed during ...
Added benefit of eribulin in breast cancer is not proven
2012-08-16
Eribulin (trade name: Halaven®) was approved in March 2011 for women with locally advanced or metastasizing breast cancer in whom the disease has progressed despite prior drug therapy.
In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether eribulin offers an added benefit compared with the present standard therapy.
According to the results of the assessment, the currently available evidence provides "hints" that eribulin ...
Ohioans love their lakes, but are concerned for their future
2012-08-16
COLUMBUS, Ohio - Almost 41 percent of Ohioans have visited a lake, pond, river or creek in the state in the past year, and of those, nearly one-half usually spend their water-related recreational time at Lake Erie, according to preliminary findings in a new report.
These figures and other findings in the report suggest that Ohio residents value their lakes and rivers, and particularly Lake Erie, as natural resources, but also help to clarify the risk that Ohioans face from contaminants in those same bodies of water, researchers say.
Among the risks: Some blue-green ...
RI Hospital: Use of PMP may increase demand for drug treatment, reduce painkiller abuse
2012-08-16
PROVIDENCE, R.I. – A Rhode Island Hospital researcher has found that the use of electronic prescription drug monitoring programs (PMPs) may have a significant impact on the demand for drug treatment programs and how prescribers detect and respond to abuse of painkillers. The study by Traci C. Green, Ph.D., MSc, research scientist in Rhode Island Hospital's department of general internal medicine, is published online in advance of print in the journal Pain Medicine.
The study surveyed 1,385 providers in Rhode Island and Connecticut on their use of state PMPs, and found ...
Enzalutamide adds 5 months survival in late-stage prostate cancer
2012-08-16
Results of a phase III clinical trial of the drug Enzalutamide, published yesterday in the New England Journal of Medicine, show the drug extends life by an average five months in the most advanced stages of prostate cancer.
"This is a major advance. Not only do we see more survival benefit than from traditional chemotherapy, but the side effects of Enzalutamide are much lower. It provides both more benefit and less harm – you get the quantification of more life, but also see quality of life improvements," says study co-author, Thomas Flaig, MD, medical director of the ...
Nature: Electronic read-out of quantum bits
2012-08-16
Quantum computers promise to reach computation speeds far beyond that of today's computers. As they would use quantum effects, however, they would also be susceptible to external interferences. Information flow into and out of the system is a critical point. Researchers from KIT with partners from Grenoble and Strasbourg have now read out the quantum state of an atom directly by using electrodes. In the Nature journal, it is reported about the stable interface between classical and quantum world. (DOI: 10.1038/nature11341)
"Normally, every contact with the outer world ...